Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trialSanjay Ramakrishnan, Mona Bafadhel, Victoria Glover et al.|The Lancet Respiratory Medicine|2023Cited by 70
Point of care blood eosinophil guided oral prednisolone for COPD exacerbations: a multi-centre double blind randomised controlled trial (The STARR2 trial)Sanjay Ramakrishnan, M Bafadhel, R Fox et al.|Unknown|2022Cited by 8